Jasper Therapeutics, Inc. · NASDAQ:JSPR
BlackRock, Inc.'s stake in Jasper Therapeutics, Inc. fell to 1.50% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc.'s stake in Jasper Therapeutics, Inc. fell to 1.50%, 225,605 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 1.50%
- Shares
- 225,605
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.50% | 225,605 |
Source
Related
- Jasper Therapeutics, Inc.
- BlackRock, Inc.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026